Tenaya Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Tenaya Therapeutics Current Ratio Growth & History (TNYA)
Tenaya Therapeutics's current ratio was 6.84 for fiscal 2025.
View full Tenaya Therapeutics company overviewTenaya Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 6.84 | 2.62 | +62.19% |
| 2024 | 2024-12-31 | 4.22 | −0.69 | −14.07% |
| 2023 | 2023-12-31 | 4.91 | −3.08 | −38.57% |
| 2022 | 2022-12-31 | 7.99 | −3.74 | −31.87% |
| 2021 | 2021-12-31 | 11.73 | −14.05 | −54.51% |
| 2020 | 2020-12-31 | 25.78 | — | — |
Tenaya Therapeutics quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.52 | −1.47 | −24.59% |
| Q1 2026 | 2026-03-31 | 5.75 | −0.92 | −13.81% |
| Q4 2025 | 2025-12-31 | 6.84 | 2.62 | +62.19% |
| Q3 2025 | 2025-09-30 | 4.64 | −0.64 | −12.11% |
| Q2 2025 | 2025-06-30 | 6.00 | −0.29 | −4.59% |
| Q1 2025 | 2025-03-31 | 6.68 | −0.04 | −0.62% |
| Q4 2024 | 2024-12-31 | 4.22 | −0.69 | −14.07% |
| Q3 2024 | 2024-09-30 | 5.27 | −1.27 | −19.41% |
| Q2 2024 | 2024-06-30 | 6.28 | −0.36 | −5.36% |
| Q1 2024 | 2024-03-31 | 6.72 | −1.29 | −16.13% |
| Q4 2023 | 2023-12-31 | 4.91 | −3.08 | −38.57% |
| Q3 2023 | 2023-09-30 | 6.55 | −2.32 | −26.17% |
| Q2 2023 | 2023-06-30 | 6.64 | −3.27 | −32.98% |
| Q1 2023 | 2023-03-31 | 8.01 | −3.19 | −28.46% |
| Q4 2022 | 2022-12-31 | 7.99 | −3.74 | −31.87% |
| Q3 2022 | 2022-09-30 | 8.87 | −11.94 | −57.38% |
| Q2 2022 | 2022-06-30 | 9.91 | −1.64 | −14.24% |
| Q1 2022 | 2022-03-31 | 11.20 | — | — |
| Q4 2021 | 2021-12-31 | 11.73 | −14.05 | −54.51% |
| Q3 2021 | 2021-09-30 | 20.80 | — | — |
| Q2 2021 | 2021-06-30 | 11.55 | — | — |
| Q4 2020 | 2020-12-31 | 25.78 | — | — |
Tenaya Therapeutics current ratio trends
Over the last five fiscal years, Tenaya Therapeutics's current ratio decreased from 25.78 to 6.84, a change of −18.94. The latest reported quarter, Q2 2026, shows 4.52.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenaya Therapeutics source filings ↗